Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
4/5/2022
Hasten Biopharma Acquires Five Cardiovascular and Metabolism Drugs fro...
4/5/2022
Chinese VMS OTC Market Up 8.4% in 2021, Driven by Higher Health Awaren...
4/5/2022
Investment into Chinese Biotech Falls Abruptly as U.S. Steps Up Scrut...
4/4/2022
U.S. Passes Bill to Curb Supply Reliance on China, with Focus on Ph...
4/3/2022
Daiichi Sankyo Disposes Chinese Rights of Cravit Formulations and Loca...
4/3/2022
SELLAS Life Sciences Signs Exclusive License Agreement with GenFleet T...
4/3/2022
Bloomberg: China Weighs Giving U.S. Full Access to Audits of Most Firm...
4/1/2022
CASI Pharma Added to SEC List of Firms Facing Possible U.S. Delisting
4/1/2022
CDE Issues the Technical Guidelines for Pharmaceutical Research and Ev...
4/1/2022
Recent Executive Moves
4/1/2022
Cancer Statistics in China and United States 2022: Profiles, Trends an...
4/1/2022
More Clouds over Multiple Fronts of Chinese Pharma as Geopolitical Ris...
3/31/2022
China's Ministry of Science and Technology Publishes Draft Rules on th...
3/31/2022
More JAK Therapies for Atopic Dermatitis Expected in China (PharmaDJ)
3/31/2022
NMPA Publishes 2021 Annual Report for Adverse Drug Reaction Monitoring
3/31/2022
CDE Solicits Comments on the Inspection Checkpoints of Drug MAHs (Draf...
3/31/2022
Financial-related Company News Digest (March 2022)
3/31/2022
Drug R&D and Product Registration News Digest March 2022 (5)
3/31/2022
Recent Executive Moves
3/30/2022
'In the Long-Term Interests': FDA Oncology Chief Defends Rejection of ...
3/30/2022
As Lilly, Innovent Hit FDA Rebuff, Another China-made PD-1 Cancer Drug...
3/30/2022
Brii Bio Enters Strategic Partnership with Sinopharm to Advance Commer...
3/30/2022
Biosion Licenses BSI-060T (Anti-Siglec-15) to Pyxis Oncology
3/30/2022
IQVIA: Chinese Retail Pharmacy Sales Up 0.6% in Q4/2021
3/30/2022
IQVIA: Chinese Biopharma Investment Hotspots and Sustainability
3/29/2022
NHC and NMPA Solicits Comments on Two Documents on Temporary Import Wo...
3/29/2022
Shanghai Lockdown May Choke Pharma Supplies (ET)
3/28/2022
Fosun Pharma Hopes Covid Vaccine Can Cure Its Ailing Margins
3/28/2022
Innovent and Lilly Expand Strategic Partnership in Oncology
3/28/2022
Upcoming Event: 5th European Meeting on Materials Science and Nanotech...
Page:
89
/
719
Total number of articles:
21546
:
[First]
[<<]
[87]
[88]
[89]
[90]
[91]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit